Seeing Is Believing
Currently out of the existing stock ratings of Jack Meehan, 35 are a BUY (56.45%), 16 are a HOLD (25.81%), 11 are a SELL (17.74%).
Analyst Jack Meehan, currently employed at STIFEL, carries an average stock price target met ratio of 98.21% that have a potential upside of 16.64% achieved within 241 days.
Jack Meehan’s has documented 140 price targets and ratings displayed on 14 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on LH, Laboratory of America Holdings at 10-Apr-2025.
Analyst best performing recommendations are on INMD (INMODE LTD).
The best stock recommendation documented was for INMD (INMODE LTD) at 11/6/2019. The price target of $22.5 was fulfilled within 5 days with a profit of $3.07 (15.8%) receiving and performance score of 31.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$84
$26.44 (45.93%)
$92
2 months 15 days ago
(06-Feb-2025)
0/3 (0%)
$18.55 (28.34%)
Hold
$73
$15.44 (26.82%)
$82
2 months 15 days ago
(06-Feb-2025)
18/20 (90%)
$7.55 (11.54%)
187
Buy
$90
$32.44 (56.36%)
$95
2 months 15 days ago
(06-Feb-2025)
3/9 (33.33%)
$24.55 (37.51%)
270
Hold
$75
$17.44 (30.30%)
$90
2 months 15 days ago
(06-Feb-2025)
3/7 (42.86%)
$9.55 (14.59%)
191
Hold
$90
$32.44 (56.36%)
$90
2 months 18 days ago
(03-Feb-2025)
14/25 (56%)
$18.28 (25.49%)
168
Which stock is Jack Meehan is most bullish on?
What Year was the first public recommendation made by Jack Meehan?